PTEN and breast carcinoma: Breast cancer patients with deficits in nuclear PTEN also had decreased breast cancer related survival than those with intact PTEN localization to the nucleus; indeed, low nuclear/high cytoplasmic PTEN immunohistochemical positivity had the worst survival of all four possible PTEN localization possibilities [121].